Biochem Biophys Res Commun

1. ZHANG X, Wen T, Chen P, Chen S, et al
   CD19 CAR-macrophage suppressed the progression of DLBCL via modulating SYK/SHP2/TBK1/TFEB signaling.
   Biochem Biophys Res Commun. 2026;832:154378.
   

   >> Share

   
   

   
   BMC Cancer

2. ZHAO J, Lian J, Wen X, Ma L, et al
   Correction to: Prognostic factors and nomogram development for adult diffuse large B-cell lymphoma: a single-center retrospective cohort study.
   BMC Cancer. 2026;26:1018.
   

   >> Share

   
   

   
   Bone Marrow Transplant

3. MANSON G, Di Blasi R, Houot R, Morschhauser F, et al
   Response kinetics following CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry.
   Bone Marrow Transplant. 2026 Aug 21. doi: 10.1038/s41409-026-03001.
   

   >> Share

   
   
4. WALKER I, Deotare U, Elemary M, Elsawy M, et al
   A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants - a study
   Bone Marrow Transplant. 2026 Aug 21. doi: 10.1038/s41409-026-03024.
   

   >> Share

   
   

   
   Br J Dermatol

5. SCARISBRICK JJ, Geskin L, Rozati S, Morsia E, et al
   Patient and care partner burden in cutaneous T-cell lymphoma using disease-specific measures of symptoms and health-related quality of life.
   Br J Dermatol. 2026 Aug 26:ljag266. doi: 10.1093.
   

   >> Share

   
   

   
   Br J Haematol

6. BARGE L, Webb L, Pelecanos A, Waters N, et al
   LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma.
   Br J Haematol. 2026 Aug 27. doi: 10.1111/bjh.70748.
   

   >> Share

   
   
7. GALLAMINI A, Viviani S, Rapezzi D, Patti C, et al
   Long-term results of brentuximab vedotin and bendamustine for first-line treatment of Hodgkin lymphoma in the elderly (HALO trial).
   Br J Haematol. 2026 Aug 26. doi: 10.1111/bjh.70763.
   

   >> Share

   
   
8. OSBORNE W, Bielby H, Cwynarski K, El-Sharkawi D, et al
   The diagnosis and management of primary mediastinal B-cell lymphoma: A British Society for Haematology guideline.
   Br J Haematol. 2026 Aug 23. doi: 10.1111/bjh.70768.
   

   >> Share

   
   
9. QIAO X, Tang Y, Yang Q, Yuan Q, et al
   Declining treatment-related and overall mortality in children with newly diagnosed advanced-stage non-Hodgkin lymphoma treated in a paediatric cancer centre during 2013-2024, Shanghai, China.
   Br J Haematol. 2026 Aug 21. doi: 10.1111/bjh.70772.
   

   >> Share

   
   
10. JAWOREK CP, Supprian M, Brockelmann PJ, Tharmaseelan H, et al
    BrECADD in three days: Implementation of a condensed intensive first-line regimen in Hodgkin lymphoma.
    Br J Haematol. 2026 Aug 21. doi: 10.1111/bjh.70771.
    

    >> Share

    
    

    
    Eur J Haematol

11. ANTONILLI S, Marklund A, Entrop J, Dietrich CE, et al
    Impact of Intensified Chemoimmunotherapy Regimens in Aggressive Non-Hodgkin Lymphoma on Reproduction Patterns.
    Eur J Haematol. 2026 Aug 25. doi: 10.1111/ejh.70303.
    

    >> Share

    
    

    
    Leuk Lymphoma

12. HAVERKOS BM, Chang C, Ristuccia R, Chang Y, et al
    Treatment utilization and outcomes in patients with mycosis fungoides and Sezary syndrome receiving mogamulizumab in community and academic practice in the United States clinical practice.
    Leuk Lymphoma. 2026;67:2035-2047.
    

    >> Share

    
    

    
    Leukemia

13. XIA C, Pradhan D, Wang W, Tang Z, et al
    Blastic plasmacytoid dendritic cell neoplasm: ontogeny, immunophenotype, genetics and epigenetics, immune dysregulation, skin tropism and therapeutic implications.
    Leukemia. 2026;40:1868-1878.
    

    >> Share

    
    
14. BEIRD HC, Kannan S, Liu J, Chen J, et al
    Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II.
    Leukemia. 2026;40:1951-1960.
    

    >> Share

    
    

    
    PLoS One

15. LUQUE-BENAVIDES R, Cruz Ku G, Valcarcel B, Garcia A, et al
    Primary ocular-adnexal non-Hodgkin Lymphoma in a Peruvian cohort: An 18-year experience.
    PLoS One. 2026;21:e0356381.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

16. HILL KK, Barry AP, Reinoso-Vizcaino NM, Haynes LE, et al
    SIRT2 deacylase modulators control B cell metabolic reprogramming in EBV infection and mitogenic activation.
    Proc Natl Acad Sci U S A. 2026;123:e2532225123.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share